We are covering topics on tissue 3D bioprinting, clinical trials in silica, quantum computing in product development, blockchain powered patient management portals, nanotechnologies, and digital therapeutics. We are also covering topics on leadership in the new pharma paradigm post COVID-19 and what it will mean to function in the new virtual world we find ourselves in. We will be asking how pharma business models will need to change and what new partnerships will need to develop as a result of this pandemic. At Impetus Digital, we believe all new, great ideas start with a conversation. And we want to initiate and house these conversations within our online collaboration platform. And then have people iterate longitudinally. Building on each other's ideas over time. One step at a time. This is how we believe positive disruption will occur.At Impetus Digital, we are leaders in delivering virtual collaboration experiences for life sciences companies. We offer the most comprehensive virtual meeting and event tools and services on the market.The Impetus InSite Platform® is a turn-key software solution that enables a “long-game” approach in connecting brands with key stakeholders, both synchronously and asynchronously. Its customizable, multilingual interface and its robust, pharma-compliant security make it the ideal choice for authentic engagement.Founded in 2008, we have over a decade of experience in virtualizing meetings and events. We offer a full range of strategic, medical writing, and digital services to help make the transition from in-person to virtual events seamless.Visit our website www.impetusdigital.com to learn more!
Gene Editing and Precision Medicine: The Future of Healthcare? with Dr. Oscar Segurado, Chief Medical Officer at ASC Therapeutics
We discuss advanced gene therapies, gene editing, personalized medicine, and much more.
CRM Design and Optimization for Life Science Organizations with John Leombruno, CEO of OkRx
We explore the impact of COVID-19 on PSPs, digital transformation, and clinical trials.
Enabling Patient-Focused Research Through Virtual Clinical Trials with Chad Walsh, CEO of Sciteline
We discuss about virtual trials, including their benefits, barriers, and impact on patient-centricity.
Innovative Approaches to Managing Mental Health Conditions with Dr. Owen Muir, Co-founder and Chief Innovation Officer at Brooklyn Minds
We deep dive into the secondary effects of COVID-19 on mental health conditions.
Risk Management, Ethics, and Compliance Considerations in the New Normal with Myriam Prescott, Head of Ethics, Risks and Compliance – Oncology, Novartis Canada
We dissect the importance of effective patient engagement and strong compliance & monitoring programs.
A Deep-Dive into the COVID-19 Pandemic and its Secondary Effects with Dr. Farah Fourcand, Author of Pandemic Manifesto
We dive into the psychological impact of COVID-19, and lessons learned from the pandemic.